CTT PHARMACEUTICAL HOLDINGS, INC. - Director, CEO - $203.5
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filingSEC EDGAR - Form 4 insider activity
Tracked equity - 3 filings indexed by Nortis
Nortis signal thesis
Buying activity is leading recent insider flow.
3
OM buys - 90d
0
OM sells - 90d
0
Routine filings
0
Cluster filings
$454.5
Largest trade
70/100
Avg signal score
Filing tape
CTT PHARMACEUTICAL HOLDINGS, INC. - Director, CEO - $203.5
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filingCTT PHARMACEUTICAL HOLDINGS, INC. - Director, CEO - $454.5
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filingCTT PHARMACEUTICAL HOLDINGS, INC. - Director, CEO - $187
Open-market purchases use the insider's own money, so they are generally more informative than awards or option mechanics.
View source filing